Dennis J. Stalker

Lake Forest College — United States

Medicine · Health Sciences

12h-index1.4kcitations24works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotics Pharmacokinetics and Efficacy(9), Antimicrobial Resistance in Staphylococcus(7), Biosimilars and Bioanalytical Methods(4), Analytical Methods in Pharmaceuticals(3), Bacterial Identification and Susceptibility Testing(3)

Publications24 total

Pharmacokinetic and Pharmacodynamic Equivalence of Epoetin Hospira and Epogen After Single Subcutaneous Doses to Healthy Male Subjects
Clinical Therapeutics·2016· 11 cited
Pharmacodynamic and Pharmacokinetic Equivalences of Epoetin Hospira and Epogen® After Multiple Subcutaneous Doses to Healthy Male Subjects
Clinical Therapeutics·2016· 7 cited
SERONEGATIVE ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE RESULTING IN DIALYSIS DEPENDENCE
American Journal of Kidney Diseases·2015Open Access
Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects
Journal of Clinical Pharmacy and Therapeutics·2012· 49 cited
Pharmacokinetics of conivaptan hydrochloride, a vasopressin V1A/V2-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study
Clinical Therapeutics·2009· 17 cited
A Review and Assessment of Potential Sources of Ethnic Differences in Drug Responsiveness
The Journal of Clinical Pharmacology·2003· 140 cited
Pharmacokinetics of Linezolid in Subjects with Renal Dysfunction
Antimicrobial Agents and Chemotherapy·2003· 214 citedOpen Access
Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers
Journal of Antimicrobial Chemotherapy·2003· 161 cited
Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone Antibacterial
Clinical Pharmacokinetics·2003· 318 cited
Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.
PubMed·2001· 252 cited
Linezolid absolute bioavailability and the effect of food on oral bioavailability
Biopharmaceutics & Drug Disposition·2001· 129 cited
Efficacy of Linezolid in Experimental Otitis Media
Antimicrobial Agents and Chemotherapy·2000· 29 citedOpen Access
Population pharmacokinetics of linezolid in subjects with a range of renal function
Clinical Pharmacology & Therapeutics·1999· 1 cited
A new model for bacterial growth & drug effects
Clinical Pharmacology & Therapeutics·1999
Population Pharmacokinetics of Glyburide in Patients with Well‐Controlled Diabetes
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy·1998· 9 cited
Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid
Diagnostic Microbiology and Infectious Disease·1997· 24 cited
Pharmacokinetics of oral glyburide in subjects with non-insulin-dependent diabetes mellitus and renal failure
American Journal of Kidney Diseases·1997· 29 cited
Secondary x-ray fluorescence for in vivo transdermal absorption measurements
International Journal of Pharmaceutics·1996· 4 cited
Noninvasive in vivo percutaneous absorption measurements using X-ray fluorescence.
Pharmaceutical Research·1992· 6 cited
Bioavailability of Flurbiprofen Following Buccal Administration
Pharmaceutical Research·1991· 12 cited
page 1 of 2Next →

Frequent Co-authors

I R Welshman(4), Michael E. Brier(3), Nancy K. Hopkins(3), Susan Reid(3), Atulkumar Ramaiya(3), Nancy Martin(3), Gail L. Jungbluth(2), George R. Aronoff(2), Donald H. Batts(2), Kristi K. Ryan(2), Wayne Wisemandle(2), T Plaum(2), Steven R. Pollock(2), Seema Kumbhat(2), J. David Robertson(2), Michael Jay(2), J G Slatter(1), Kenneth L. Feenstra(1), Jon Bruss(1), James P. Sams(1)